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Background. The dual task paradigm (Baddeley et al. 1986 ; Della Sala et al. 1995) has been proposed as a sensitive
measure of Alzheimer’s dementia, early in the disease process.
Method. We investigated this claim by administering the modified dual task paradigm (utilising a pencil-and-paper
version of a tracking task) to 33 patients with amnestic mild cognitive impairment (aMCI) and 10 with very early
Alzheimer’s disease, as well as 21 healthy elderly subjects and 17 controls with depressive symptoms. All groups were
closely matched for age and pre-morbid intellectual ability.
Results. There were no group differences in dual task performance, despite poor performance in episodic memory
tests of the aMCI and early Alzheimer’s disease groups. In contrast, the Alzheimer patients were specifically impaired
in the trail-making test B, another commonly used test of divided attention.
Conclusions. The dual task paradigm lacks sensitivity for use in the early differential diagnosis of Alzheimer’s disease.
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Introduction
Alzheimer’s disease (AD) is the most common form
of dementia, estimated to rise dramatically in the
future (Wimo et al. 2003). Research has focused on
early accurate diagnosis and intervention. The con-
struct ‘amnestic mild cognitive impairment’ (aMCI;
Peterson et al. 2001) has become increasingly popular
to predict those who are most at risk for developing
dementia. It is considered a transitional stage between
normal ageing and the earliest clinical diagnosis of AD
(Petersen, 2005 ; Petersen & O’Brien, 2006). Research
on clinic-based samples has suggested that the con-
version rate from aMCI to dementia is 10–15% per
year (e.g. Petersen et al. 1999 ; Storandt et al. 2006)
compared with between 1% and 2% in a normal age-
matched non-clinical sample.
While primary impairment in very early AD in-
cludes episodic memory function, many authors have
reported that attention and executive functioning are
also vulnerable at this stage (Parasuraman & Haxby,
1993 ; Perry & Hodges, 1999). In particular, people
with early AD exhibit marked difficulty dividing
their attention between two concurrent tasks. By
comparing performance of a synchronous dual task
with that of identical task components done separately
and consecutively, a deficit in dual performance can
be attributed to failure of the central executive that
coordinates the simultaneous operation of these com-
ponents (Baddeley et al. 1986). One advantage of the
dual task paradigm is that it avoids modality-specific
interference between tasks : the tracking task is pres-
ented visually and a manual response is required;
information for the digit span task is presented aurally
with a verbal response (Nebes et al. 2001). A further
strength is that task demands can be fixed at individ-
ual ability levels, controlling for individual variation
in performance in the component parts of the dual
task. Therefore, each patient is his or her own control,
adjusting for the generally poorer performance of AD
patients in the baseline tasks (Logie et al. 2004).
Research has suggested that failure of the ‘coordi-
nation’ function is characteristic of mild AD in a lab-
oratory setting. Participants with mild AD appear to
* Address for correspondence : Professor K. P. Ebmeier, University
of Oxford, Section of Old Age Psychiatry, Warneford Hospital,
Oxford OX3 7JX, UK.
(Email : Klaus.ebmeier@psych.ox.ac.uk)
Psychological Medicine (2009), 39, 23–31. f 2008 Cambridge University Press
doi:10.1017/S0033291708003346 Printed in the United Kingdom
ORIGINAL ARTICLE
be impaired, irrespective of task demands, and this
impairment has been found to worsen with illness
progression (Baddeley et al. 1986, 1991 ; MacPherson
et al. 2004). Proponents of the dual task paradigm
suggest such findings are in contrast to normal ageing,
which they believe has a relatively minor effect on
dual task performance (e.g. Baddeley et al. 1986 ;
Hartley & Little, 1999; Logie et al. 2004 ; but see
Crossley & Hiscock, 1992). The equipment used for
this test is often an expensive computerized tracking
device impractical for clinical settings (e.g. Baddeley
et al. 1991 ; Logie et al. 2004). Della Sala et al. (1995)
developed a modified pencil-and-paper version of
the tracking component for the dual task. This has
been reported to produce results comparable with
the original instrument (Della Sala et al. 1995 ;
Sebastian et al. 2006). To our knowledge the dual task
paradigm has not been investigated with a sample
defined according to recent aMCI criteria (Petersen
et al. 1999).
The aim of this study was therefore to assess dual
task performance in aMCI to ascertain whether this
measure can be useful in the early diagnosis of AD.
As AD is associated with a specific impairment in
the aspect of working memory that coordinates per-
formance of two separate tasks, we predicted that
the performance of people with aMCI and very early
AD should be significantly lower than that of aged
matched controls. Furthermore, the inclusion of a
group of elderly patients with symptoms of depression
would test the specificity of dual task impairments
in AD. On the basis of the previous research, we pre-
dicted that the depressed group would show impair-
ment in the dual task compared with controls.
Method
Participants
We examined 33 patients with aMCI, 10 early AD
patients, 17 control out-patients with depressive
symptoms and 21 healthy elderly controls, following
a protocol approved by the local ethics of research
committee. All participants also took part in a larger
longitudinal study of neuropsychological markers in
pre-clinical AD. The aMCI patients were recruited
over a 2-year period (September 2003–September
2005) from tertiary referrals to the local neuropsycho-
logical assessment service for older adults and met
criteria for aMCI (Petersen et al. 1999). MCI patients
had to give subjective reports of memory difficulty
corroborated by an informant and exhibit objective
memory impairments on neuropsychological tests
of episodic memory. In terms of impairments on
tests of episodic memory, 13 participants showed an
impairment of more than 2 standard deviations (S.D.)
below our control mean on two or more tests, a further
four showed impairments of 1.5 to 2 S.D. on two or
more tests, 12 participants were impaired at 1–1.5 S.D.
below control means on two or more tests, and the
final four participants performed more than 1 S.D.
below controls on one episodic memory test. All aMCI
patients underwent comprehensive neuropsychologi-
cal and psychiatric evaluation and medical screening
prior to study entry, as well as neuroimaging before
or during the study period, if thought to be clinically
indicated by the responsible specialist, i.e. in 24 of
the 33 participants in this group. Exclusion criteria
for the aMCI group were a diagnosis of dementia or
other medical/neurological conditions which may
account for memory loss, untreated depressive illness,
significant or predominant cerebrovascular disease
on neuroimaging, significant motor and/or visual
problems or an age below 58 years. Mini Mental State
Examination (MMSE) scores ranged from 24 to 30,
with a mean of 28.3. The final aMCI group consisted
of 15 males and 18 females with a mean age of 73.3
years (range 58–85 years).
For the healthy elderly control group (MMSE
28–30), we recruited spouses or carers of patients who
had attended the service. Potential participants were
excluded if there was a history of medical, psychiatric
or neurological conditions (i.e. stroke or cerebrovas-
cular disease, head injury, alcoholism, schizophrenia,
etc) that could conceivably affect cognitive function-
ing. The healthy elderly control group was matched
as closely as possible to the aMCI and early AD groups
in terms of age and estimated pre-morbid intelligence
quotient (IQ). The final elderly control group consisted
of eight males and 13 females with had a mean age
of 69.5 years (range 59–81 years).
Ten participants diagnosed with AD, in accordance
with National Institute of Neurologic, Communicative
Disorders and Stroke–AD and Related Disorders
Association (NINCDS-ADRDA; McKhann et al. 1984)
and DSM-IV (APA, 1994) diagnostic criteria, took
part in the current study. AD patients were recruited
from tertiary referrals to our neuropsychology service
or via referrals to the local old age psychiatry service.
All early AD patients scored above 23/30 on the
MMSE and above 65/100 on the more comprehen-
sive Addenbrooke’s cognitive examination (ACE;
Mathuranath et al. 2000), indicating relatively mild
disease. Patients had undergone relevant medical
screening and neuroimaging, together with compre-
hensive psychiatric and neuropsychological evalu-
ation as part of their initial diagnostic workup. The
final early AD group consisted of three males and
seven females with a mean age of 73.6 years (range
65–81 years).
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Seventeen participants with depressive symptoms
(MMSE 25–30) were recruited via local psychiatric
out-patient clinics and day hospitals. In an attempt
to match this patient group with the aMCI group in
terms of illness severity, patients with milder forms
of depression were included. Fifteen of the 17 partici-
pants were receiving treatment for their symptoms
at the time of testing ; all but two of these pharma-
ceutical in nature. As it has been suggested that type
of depression does not influence the magnitude of
cognitive deficits (Christensen et al. 1997), participants
with a variety of disorders were included. Eight
patients had a history of major depression, two of
bipolar disorder, two were suffering from anxiety
disorders with depressive features, three were con-
sidered dysthymic and two were considered to be
suffering with a subclinical level of depressive symp-
toms.Mean geriatric depression scale (30-item version)
score for this group was 13.2 (range 0–27). We once
again excluded patients with any medical, neurologi-
cal or psychiatric condition with a known potential to
affect cognitive function. The group consisted of three
males and 14 females with a mean age of 73.3 years
(range 65–84 years). Subjects gave informed written
consent to the whole protocol which was approved by
the Lothian Research Ethics Committee ; the research
was completed in accordance with the Helsinki
Declaration.
Neuropsychological tests
All participants completed a variation on the modi-
fied dual task paradigm (Della Sala et al. 1995). This
pencil-and-paper test of divided attention consists of
two components (a digit span task and a visuospatial
tracking task) that are each performed on their own
before being performed concurrently. First, partici-
pants’ digit span was determined. This involved re-
peating strings of digits read by an experimenter at
a rate of approximately two per s. Initially, two-digit
strings were presented and these increased one digit
at a time if the participant correctly recited five of
six examples of each length. When the participant
failed to recite two or more strings of the same span,
digit span for that person was considered to be the
previous length. No time limit was imposed at this
stage. Having determined the participants’ individual
digit span, participants had 90 s to recite as many digit
strings, fixed at the individual participants’ digit
span, as possible (digit span – single). Responses were
recorded as correct for each digit recited in the correct
order.
Following this, participants completed the tracking
task (Della Sala, 1999). An A3-sized sheet with 319
empty circles linked by a meandering line was
presented to the participant. The participant was in-
structed to trace a line though circles, following the
line that was already there, without lifting the pen
from the paper. Participants had 90 s for this trial, and
the number of circles reached during this time was
recorded (tracking – single). The final trial was the
concurrent dual task. Here participants had 90 s to
simultaneously perform both tasks : recite digit
strings fixed at their digit span (digit span – dual) as
well as carrying out a tracking task identical to the
one used above (tracking – dual). In order to take
into account the various strategies one may adopt in
performing the two tasks simultaneously, an overall
decrement score was calculated using the following
formula :
m=(1x[(Pm+Pt)=2])r100,
where m is the combined dual task score, Pm is
the proportional loss in span performance between
single (Xsingle) and dual task (Xdual) conditions,
[(Xsingle – Xdual)/Xsingle] while Pt is the equivalent
proportional loss in tracking score. Thus a score of
100 would represent no dual task decrement and
lower scores reflect greater dual task decrements.
A number of further tests were administered as part
of the longitudinal investigation of neuropsycho-
logical markers. These included measures of general
cognitive ability, such as the ACE, the more widely
known MMSE and the National Adult Reading Test,
revised version (NART-R; Nelson & Willison, 1991).
The NART-R was used to provide an estimate of
the pre-morbid level of intellectual functioning. Epi-
sodic memory was assessed using the Hopkin’s
verbal list test, revised (HVLT-R; Brandt, 1991) and
the paired associates learning test (PAL) from the
Cambridge automated neuropsychological test battery
(Swainson et al. 2001). Participants also completed
the trail-making test (TMT) part A and B (Reitan,
1985), considered a measure of attention and executive
functioning.
The HVLT-R requires participants to recall as many
words as possible immediately following presentation
of a 12-item word list. The word list is presented on
three consecutive learning trials. The participant is
also required to recall, and finally recognize, as many
words from the list as he or she is able, following a
delay of 30 min. The PAL is a computerized measure
of visuospatial learning requiring participants to learn
the locations of an increasing number (i.e. 1, 2, 3, 6 and
then 8) of patterns (Swainson et al. 2001). The score
of interest was the number of pattern-position errors
at the six pattern level. The TMT A requires tracing
a line linking numbers in ascending order, while
for the TMT B participants have to connect numbers
and letters alternatively in ascending order : the
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participant has to divide his/her attention back and
forth between multiple lines of thought.
Each of these measures has been shown to be
sensitive to very early AD (Chen et al. 2000 ; Nathan
et al. 2001 ; Swainson et al. 2001 ; Hogervorst et al.
2002 ; Blackwell et al. 2004; Stokholm et al. 2006).
Neuropsychological assessments lasted approximately
90 min in total. The order of test administration was
identical for all assessments.
Statistics
Data were analysed using SPSS 12.0 for Windows
(SPSS Inc., Chicago, IL, USA). Demographic variables
were analysed using univariate analysis of variance
(ANOVA), and Tukey honestly significantly different
pairwise comparisons were carried out on all signifi-
cant analyses where possible. Where the assumption
of homogeneity of variance was not met, this was
adjusted for using Games–Howell post-hoc pairwise
comparisons, given that the sample sizes were
unequal in the current analysis. A univariate ANOVA
was carried out on the overall decrement score (see
above). Decrement scores broken down into tracking
decrement and digit span decrement were also calcu-
lated and examined using ANOVAs. Two participants
in the early AD group were incapable of completing
the TMT B; in these cases a default ceiling score of
500 s to completion was applied.
Results
Participant characteristics
Demographic matching characteristics are presented
in Table 1. There were no group differences in age
[F(3, 77)=1.73] or estimated pre-morbid full-scale IQ
[F(3, 75)=0.55]. The mean MMSE score for the early
AD group was, as expected, significantly lower than
that of the other groups [F(3, 77)=17.70, p<0.0001]
(AD v. healthy controls, p=0.001; AD v. controls with
depressive symptoms, p<0.005; AD v. controls,
p<0.005). No other group differences in mean MMSE
score were noted. As expected, the early AD patients
had significantly lower mean ACE scores than did
all other groups [F(3, 77)=29.30, p<0.0001] (post-hoc
tests as above in all cases, p<0.0001). The ACE also
discriminated between normal elderly control partici-
pants and aMCI patients, with the latter group ob-
taining a significantly lower mean ACE score (post hoc
p=0.01).
Dual task performance
Group means and S.D.s for the digit span task and
the tracking measures of the modified dual task
paradigm are presented in Table 2. Mean percentage
scores for performance on the concurrent tasks, the
digit span tasks and the visuospatial tracking tasks
for each of the four groups are presented in Table 3.
On carrying out a one-way non-repeated ANOVA on
the overall decrement score, no group difference was
found [F(3, 77)=0.63]. Similarly, no significant group
differences were found for any of the other component
tasks or decrement scores.
Other cognitive functions
Group mean scores and S.D.s for the HVLT-R, the
number of errors at the six pattern level of the PAL
and the TMT B are presented in Table 4. On analysing
the HVLT-R delayed recall data, there was a signifi-
cant group effect [F(3, 77)=12.39, p<0.0001]. On closer
analysis, the AD group recalled significantly fewer
words than the healthy control (p<0.0001) and de-
pression groups (p<0.0001). Similarly, the aMCI










Males (n) 8 3 16 3
Females (n) 13 14 17 7
Age 69.5 (7.3) 73.3 (6.6) 73.1 (6.3) 73.6 (5.8) –
NART 118.2 (2.9) 116.8 (6.2) 116.3 (8.5) 115.6 (5.5) –
MMSEa 29.1 (0.7) 28.6 (1.5) 28.4 (1.6) 25.0 (2.3) Controls=depression=aMCI>AD
ACE 94.6 (3.3) 91.7 (5.0) 89.0 (5.6) 76.7 (6.6) Controls>aMCI>AD
Depression>AD
aMCI, Amnestic mild cognitive impairment ; AD, Alzheimer’s disease ; NART, National Adult Reading Test ; MMSE,
Mini Mental State Examination ; ACE, Addenbrooke’s cognitive examination.
Values are given as mean (standard deviation).
a Games–Howell multiple comparison carried out due to lack of homogeneity of variances.
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group performed more poorly than the healthy control
(p<0.005) and depression groups (p<0.01). No sig-
nificant difference was found between the AD and
aMCI groups. The performance of the elderly control
and depression groups on the HVLT-R delayed recall
did not differ. However, the AD group made signifi-
cantly more errors at the six pattern stage of the PAL
compared with all other groups [F(3, 755)=22.82,
Table 2. Digit span and individual component measures of the dual task (span and










Digit span 5.5 (0.7) 5.8 (1.0) 5.6 (0.9) 5.1 (0.7)
Digit span (single)a 1.0 (0.03) 0.9 (0.05) 1.0 (0.05) 1.0 (0.03)
Digit span (dual)a 0.9 (0.05) 0.9 (0.08) 0.9 (0.08) 1.0 (0.02)
Tracking (single)b 141 (56.5) 140 (51.7) 126 (38.9) 120 (46.3)
Tracking (dual)b 122 (46.0) 126 (58.3) 114 (36.3) 107 (35.6)
aMCI, Amnestic mild cognitive impairment ; AD, Alzheimer’s disease.
Values are given as mean (standard deviation).
a Proportion of digits recalled in the correct position (1=all correct).
b Number of circles joined in 90 s.
Table 3. Percentage loss of performance in component tasks and overall decrement score










Digit span 96 (3.8) 97 (8.6) 98 (7.6) 100 (3.3)
Tracking 90 (22.8) 88 (16.8) 92 (15.4) 93 (17.6)
Overall decrement 93 (11.1) 92 (8.2) 95 (8.6) 97 (9.1)
aMCI, Amnestic mild cognitive impairment ; AD, Alzheimer’s disease.
Values are given as mean (standard deviation).
a Percentage loss of performance scores were calculated as (1x[(XsinglexXdual)/
Xsingle])r100 and the overall decrement score as m=(1x[(Pm+Pt)/2])r100, as
described in the Method section.










HVLT-R delay 8.1 (2.8) 8.1 (3.3) 4.9 (3.3) 2.1 (3.7) Controls=depression >aMCI=AD
PAL errorsa 7.8 (6.9) 10.9 (7.8) 16.5 (12.9) 40.7 (10.6) Controls, depression, aMCI<AD
Controls <aMCI
TMT A 40.3 (11.2) 54.1 (23.1) 49.6 (36.1) 57.6 (25.3) –
TMT B 87.6 (31.5) 134.2 (53.6) 106.3 (49.4) 216.7 (157.7) Controls<depression
Controls, depression, aMCI<ADb
aMCI, Amnestic mild cognitive impairment ; AD, Alzheimer’s disease ; HVLT-R, Hopkins verbal learning test, revised ; PAL
errors, six pattern stage errors from the paired associates learning test ; TMT A, trail-making test part A; TMT B, trail-making test
part B.
Values are given as mean (standard deviation).
a Games–Howell multiple comparison was used because of unequal variances.
b After removing effects of TMT A (see text).
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p<0.0001] (post hoc tests comparing AD with other
groups were in all cases p<0.0001). The aMCI group’s
error scores fell between those of the healthy control
and AD groups, and significantly differed from both
of these (aMCI v. healthy controls, p<0.05 ; aMCI
v. AD, p<0.0001). A significant group effect was also
found for the TMT B [F(3, 77)=8.62, p<0.0001]. In the
post hoc analyses, only the control and depression
groups differed in terms of TMT B scores (p<0.05) ;
participants with depressive symptoms took signifi-
cantly longer to complete the task. However, once
time to completion on TMT part A (a measure of
psychomotor speed) was statistically controlled for,
a different pattern of group differences emerged
[F(3, 76)=7.76, p<0.0001]. Specifically, it was found
that the participants with AD took longer to complete
the second task compared with all other groups (aMCI
v. AD, p<0.0001; healthy controls v. AD, p<0.0001;
controls with depressive symptoms v. AD, p<0.05).
The group difference between the control and depres-
sive symptom groups was no longer significant. No
other group differences were uncovered.
Discussion
This study investigated the claim that the dual task
paradigm can be used in the early diagnosis of de-
mentia of the Alzheimer’s type. We assessed the
concurrent performance of a visuospatial tracing task
and a digit span forward task in four diagnostic
groups with aMCI (MMSE 24–30), early AD (MMSE
23–29), symptoms of depression (MMSE 25–30) and
healthy elderly controls (MMSE 28–30). Our results
show that aMCI is not associated with impaired dual
task performance ; those with aMCI had comparable
performance to healthy older adults and older adults
with depressive symptoms. Our early AD group was
similarly unimpaired on the modified dual task para-
digm relative to depressive and non-depressive
elderly control groups and the presence of depressive
symptoms appeared to have no effect on dual task
performance. By contrast, and indeed by definition,
episodic memory impairments were present in the
aMCI and early AD groups. The early AD group also
exhibited an impaired ability to divide their attention
at pace, as indicated by part B of the TMT.
These results shed some light on previous findings.
One line of research has suggested that dual task
performance is vulnerable to the influence of AD, even
early in the disease course (Baddeley et al. 2001 ; Logie
et al. 2004). However, such studies generally involve
participants varying in severity from minimal to mild
AD. When participants with AD are divided by
severity using the MMSE, only the more severely ill
patients (e.g. MMSE <24) are impaired on the dual
task paradigm (Greene et al. 1995; Perry et al. 2000;
Crossley et al. 2004). This result is in agreement with
the absence of impairment on the dual task measure
observed in the current study in early AD. The com-
bined findings suggest that dual task impairments
are generally not observed early on in the AD process,
with MMSE scores above 23/30.
Only one other study has investigated the dual
task performance of a group of older adults with cog-
nitive impairment without a diagnosis of dementia
(Holtzer et al. 2004). Cognitively impaired adults,
defined by a dementia rating scale (DRS) cut-off score
of <124 (Mattis, 1988), performed two tasks in dif-
ferent modalities at the same time. Two combinations
of tests were used: a visual cancellation task (where
participants were required to cross out a specified
stimulus type from a field of stimuli) combined with a
digit span task, and the same visual cancellation task
combined with a verbal fluency task. The researchers
report that their cognitively impaired group exhibited
a significantly larger dual task decrement than age-
matched controls. However, the cognitively impaired
group in the Holtzer et al. (2004) study was identified
solely on the basis of a DRS cut-off score falling at
or below levels that are indicative of an underlying
dementia. It is for this reason difficult to be certain
of, or to compare, disease severity of this ‘minimally
cognitively impaired’ group with other studies, which
commonly use well-established clinical and research
criteria to define patient groups. Furthermore, the
cognitively impaired group in the Holtzer et al. (2004)
study were significantly less well educated than the
control groups, while in the current study participant
groups were well matched both in terms of age and
estimated levels of pre-morbid intelligence.
Holtzer et al. (2004) did not investigate the potential
influence of depression on dual task performance.
This is crucial where consideration is being given
to the early and differential diagnostic value of a
neuropsychological measure. Hasher & Zacks (1979)
confirmed our result that people with depression
show impaired attention during effortful processing
tasks, for instance on measures of divided attention
such as the TMT B (Nathan et al. 2001; Mahurin et al.
2006). Only one study has investigated the effect
of depressive symptoms on Baddeley et al.’s (1986)
original dual task paradigm (Nebes et al. 2001). This
indicated that people with depression had a signifi-
cantly greater decrement in computerized tracking
performance and a composite decrement measure
than non-depressed controls. No study to date has
investigated the effects of clinically depressed mood
on the modified version of the dual task paradigm to
replicate or contradict our negative result (Della Sala
et al. 1995).
28 J. A. Lonie et al.
A strength of the current investigation relates to
the availability of additional neuropsychological data
demonstrating the existence of significant episodic
memory impairments in aMCI and early AD and ad-
ditional impairment of speeded divided attention (as
assessed by TMT B) in early AD. The TMT B assesses
the ability to divide attention back and forth between
multiple lines of thought (connecting numbers and
letters, respectively), but differs from the dual task
paradigm in that its different components are not
drawn from separate modalities. Performance is thus
more vulnerable to reduced processing capacity.
Several previous studies have demonstrated that TMT
B is impaired in the very early and even pre-clinical
stages of AD (Lafleche & Albert, 1995 ; Arnaiz et al.
2000 ; Perry et al. 2000; Nathan et al. 2001; Crowell et al.
2002 ; Crossley et al. 2004; Alladi et al. 2006 ; Baudic
et al. 2006; Stokholm et al. 2006), although its specificity
for AD, as distinct from, for example, depression, has
not been established.
The Holtzer et al. (2004) study compared the dual
task performance of minimally cognitively impaired
participants only with their performance on tests com-
prising the single task conditions (i.e. visual cancel-
lation, digit span and letter fluency). However, these
tests are not, generally speaking, associated with im-
pairments in very early and pre-clinical AD and it is
therefore not surprising that they are insensitive to
cognitive deficits in the minimally impaired group,
as was the case in this study.
One important methodological feature may have
influenced the current results : While those studies
reporting general dual task impairment in early
AD used both computerized and pencil-and-paper
versions of the tracking task, only the modified
version utilising the pencil-and-paper tracking task
(Della Sala et al. 1995) has been used in studies that
separated participants by symptom severity. Thus,
while patients who are minimally affected do not
show impairments on the modified version of the
task, it remains possible that they would show im-
pairments if the test were more taxing – for instance
if the dual task paradigm included the original com-
puterized version of the tracking task. This version of
the task requires increased effort and attention, as
participants are required to adjust to an external influ-
ence (i.e. the speed of the light dot on the screen)
rather than working at a self-defined rate. It may
therefore be sufficiently taxing to identify those
who are not picked up by the more straightforward
pencil-and-paper tracking task. However, the paper-
and-pencil version (as opposed to the computerized
task) is more likely to be adopted for widespread use
in clinical and research practice, which underscores
the relevance of our negative result.
A further methodological issue is the variability
of dual task administration, which can lead to diffi-
culties comparing findings across studies. We ad-
ministered each of the three trials in blocks of 90 s,
while some previous studies set the trial time at 120 s
(e.g. Perry et al. 2000). Most dual task studies have
utilized pencil-and-paper tracking tasks that required
participants to cross out boxes on an A4-size sheet
of paper to form a chain (e.g. Baddeley et al. 1997).
The current task required participants to trace a
line through linked empty circles on an A3-size
sheet. While the initial dual task paradigm involved
recording the number of completely correct digit
strings (Baddeley et al. 1986), many subsequent
studies, including the current investigation, have cal-
culated the number of digits recalled in the correct
order for this measure. The significance of such alter-
ations to dual task administration requires further
investigation.
A partial alternative explanation for our negative
result is that a majority of individuals forming our
aMCI group may fail to convert to AD in the future.
If this proves to be the case, then the absence of
dual task impairment would not be surprising.
The issue will be resolved through the longitudinal
follow-up of participants with aMCI, currently under-
way. However, the sound performance of our early
AD group on the dual task measure makes it more
likely that the negative result for our aMCI patients
is due to lack of test sensitivity rather than absence
of underlying AD pathology. The impaired per-
formance of the early AD group on an alternative
popular measure of speeded divided attention implies
that the dual task measure lacks sensitivity to very
early changes of an attentional/executive nature
in AD.
In conclusion, people with early AD and aMCI did
not display impaired performance on the modified
version of the dual task paradigm at a time when
episodic memory, and in the case of early AD, speeded
divided attention, were significantly impaired. The
likely explanation is that the dual task paradigm is
insufficiently sensitive for use as an adjunctive cog-
nitive tool in the early diagnosis of AD. Future longi-
tudinal research is needed to investigate the use of
dual task tests of varying demand in aMCI and very
early AD participants in an effort to determine the
potential influence of task demands and complexity
on performance.
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